SCHEMBL14286148

SCHEMBL14286148

O=C(c1cc(-c2nncn2-c2cccc(F)c2F)c[nH]1)N1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.42
MAPK10 P53779 1/20 0.42
HPGD P15428 2/20 0.42
ALDH1A1 P00352 5/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ATP4A P20648 2/20 0.37
ATP4B P51164 2/20 0.37
POLB P06746 1/20 0.35
HRH4 Q9H3N8 6/20 0.35
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5037077 0.90 ALDH1A1 (0.36) MAPK1MAPK10HPGDALDH1A1HTT
SCHEMBL5037204 0.85 NOTUM (0.36)
SCHEMBL14286134 0.82 MAPK1 (0.46) MAPK1MAPK10HPGDALDH1A1HTT
SCHEMBL14600761 0.80 HPGD (0.42) MAPK1HPGDALDH1A1LMNAMEN1
SCHEMBL5034026 0.79 MAPK7 (0.42) MAPK1ALDH1A1LMNAMEN1KMT2A
SCHEMBL14286139 0.79 ROCK2 (0.40) MAPK1MAPK10MEN1KMT2A
SCHEMBL5784221 0.76 HCAR1 (0.39) ALDH1A1
SCHEMBL14278772 0.75 MAPK1 (0.49) MAPK1MAPK10HPGDALDH1A1HTT
SCHEMBL5038382 0.73 MAPK1 (0.49) MAPK1MAPK10HPGDALDH1A1HTT
SCHEMBL14286171 0.73 MAPK1 (0.52) MAPK1MAPK10HPGDALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7314885-B2 Pyrrole compounds useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-01 US disclosed
US-7314885-B2 Pyrrole compounds useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-01 US disclosed